Madrigal Pharmaceuticals, Inc.
(Borse Berlin : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SHPGShire PLC Sponsored ADR
VRXValeant Pharmaceuticals International, Inc.
SAGESAGE Therapeutics, Inc.
PRGOPerrigo Co. Plc
ICPTIntercept Pharmaceuticals, Inc.
JAZZJazz Pharmaceuticals Plc
GWPHGW Pharmaceuticals PLC Sponsored ADR
PCRXPacira Pharmaceuticals, Inc.
UTHRUnited Therapeutics Corporation
MNKMallinckrodt Plc
CTLTCatalent Inc
SUPNSupernus Pharmaceuticals, Inc.
PTLAPortola Pharmaceuticals, Inc.
MDCOMedicines Company

Company Profile

Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.